Roche Holding AG (RHHVF) Gets a Buy Rating from Barclays

Barclays analyst Emily Field maintained a Buy rating on Roche Holding AG (RHHVF) today and set a price target of CHF375.00. The company’s shares closed last Tuesday at $338.72.

According to, Field is ranked #6718 out of 7459 analysts.

The word on The Street in general, suggests a Hold analyst consensus rating for Roche Holding AG with a $373.41 average price target, representing a 11.0% upside. In a report issued on April 7, Goldman Sachs also maintained a Buy rating on the stock with a CHF441.00 price target.

See today’s analyst top recommended stocks >>

Roche Holding AG’s market cap is currently $289B and has a P/E ratio of 17.90. The company has a Price to Book ratio of 17.43.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts